Publication | Closed Access
Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.
65
Citations
0
References
2005
Year
Hematological MalignancyNeuro-oncologyNon-myeloablative Allogeneic TransplantationTransplantationMarrow TransplantationBortezomib TherapyStem Cell TransplantationHematologyMyeloid NeoplasiaMultiple MyelomaSuccessful UseCell TransplantationBlood TransplantationExtramedullary RelapseMedicineRadiation OncologyHealth Sciences
We report the successful use of bortezomib to treat a patient with multiple myeloma (MM) who had extramedullary relapse (paraspinal and thoracic masses and multiple cranial nerve palsy) after autologous and non-myeloablative allogeneic hematopoietic stem cell transplantation (HSCT).